Jump to top navigation | Jump to main navigation | Jump to content
Therapeutic Goods Administration logo

Compositional guideline: Hydroxycitrate complex

Definition of substance

Hydroxycitrate complex is derived from the fruit rind of Garcinia quaesita Pierre, or Garcinia zeylanica Roxb. It contains one or more of the three salts (calcium, potassium or sodium hydroxycitrate) of hydroxycitric acid. Varying amounts of plant material from G. quaesita or G. zeylanica may still be present in the substance depending on the manufacturing process employed, but should not exceed 10% of the final preparation.

This compositional guideline is applicable to each of the salts of hydroxycitric acid as defined above and also applies to mixtures of the above salts.

Specifications

Test Limits Method
Appearance Cream to white colour powder Visual
Identification

Positive

Calcium
Potassium
Sodium

TLC or HPLC

AAS or ICP-MS*
AAS or ICP-MS*
AAS or ICP-MS*

Assay

NLT 50% by weight hydroxycitric acid

NMT 20% by weight lactone of hydroxycitric acid

NMT 10% by weight citric acid

HPLC

HPLC

HPLC

Specific optical rotation -10° to -20° BP Appendix V F. Determination of optical rotation and specific optical rotation
Moisture NMT 10% USP <921> Method III
Heavy metals NMT 20 ppm
(expressed as Pb)
BP limit test
Microbiology Complies TGAL Guidelines for Assessing the Results of Microbiological Tests on Non-Sterile Pharmaceuticals for Human Use
Pesticide residues Complies BP
Residual solvents Complies BP

Key to abbreviations:

  • TLC = thin layer chromatography
  • HPLC = high pressure liquid chromatography
  • AAS = atomic absorption spectroscopy
  • ICP-MS = inductively coupled plasma - mass spectrometry
  • NLT = not less than
  • NMT = not more than
  • BP = British Pharmacopoeia
  • USP = United States Pharmacopoeia
  • TGAL = TGA Laboratories
  • * = only tested if present

Important Note - Labels must declare the amount of hydroxycitrate complex, and the equivalent amount of hydroxycitric acid that is present. In the case of sodium hydroxycitrate, the amount of sodium should be declared where the total sodium content of the formulation is greater than 120 mg of sodium per maximum recommended daily dose (refer to Therapeutic Goods Order No. 69 General Requirements for Labels for Medicines <http://www.tga.gov.au/docs/html/tgo/tgo69.htm>).

Top of page